20 - Clinical Impact of Herpesviruses: Beyond Neonates and the Immunocompromised

Speaker(s)

• 

  Paul Griffiths, MD, DSc

  Professor of Virology
  Royal Free Hospital London
  London, England, United Kingdom

  Disclosure: GSK : Advisor or Review Panel member (Status: Ongoing); Hookipa : Advisor or Review Panel member (Status: Terminated --- 2019); Roche : Advisor or Review Panel member (Status: Terminated --- 2019); shire : Advisor or Review Panel member (Status: Ongoing)
• AL

  Ajit Limaye

  University of Washington
  Seattle, Washington

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit

No CPE Credits

Learning Objectives:

• describe current evidence linking herpes-viruses to mortality
• describe current evidence linking herpes-viruses to worse outcomes in ICU patients
• summarize the evidence for and proposed mechanisms for CMV-associated inflammatory bowel disease

Presentations:

• 12:30pm – 1:45pm EDT

  CMV and Mortality in the General Public
  Paul Griffiths, MD, DSc – Royal Free Hospital London
• 12:30pm – 1:45pm EDT

  CMV in Critical Illnesss
  Ajit Limaye – University of Washington